nsP4 Is a Major Determinant of Alphavirus Replicase Activity and Template Selectivity.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
27 09 2021
Historique:
pubmed: 29 7 2021
medline: 30 12 2021
entrez: 28 7 2021
Statut: ppublish

Résumé

Alphaviruses have positive-strand RNA genomes containing two open reading frames (ORFs). The first ORF encodes the nonstructural (ns) polyproteins P123 and P1234 that act as precursors for the subunits of the viral RNA replicase (nsP1 to nsP4). Processing of P1234 leads to the formation of a negative-strand replicase consisting of nsP4 (RNA polymerase) and P123 components. Subsequent processing of P123 results in a positive-strand replicase. The second ORF encoding the structural proteins is expressed via the synthesis of a subgenomic RNA. Alphavirus replicase is capable of using template RNAs that contain essential

Identifiants

pubmed: 34319783
doi: 10.1128/JVI.00355-21
pmc: PMC8475546
doi:

Substances chimiques

Polyproteins 0
RNA, Viral 0
Viral Nonstructural Proteins 0
Viral Replicase Complex Proteins 0
RNA-Dependent RNA Polymerase EC 2.7.7.48
DNA-Directed RNA Polymerases EC 2.7.7.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0035521

Subventions

Organisme : UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BBS/E/I/00007033 BBS/E/I/00007038 and BBS/E/I/00007039
Organisme : Estonian Research Council
ID : PRG1154
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007039
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust (Wellcome)
ID : 200171/Z/15/Z
Organisme : EC | European Regional Development Fund (ERDF)
ID : 2014-2020.4.01.15-013
Organisme : Medical Research Council
ID : MC_PC_16028
Pays : United Kingdom
Organisme : Research Foundation Flanders
ID : KAN1526318N
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007038
Pays : United Kingdom

Références

J Virol. 1993 Apr;67(4):1916-26
pubmed: 8445717
RNA. 2001 Nov;7(11):1638-51
pubmed: 11720292
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8967-71
pubmed: 1924357
J Virol. 2017 Aug 24;91(18):
pubmed: 28701392
J Virol. 2015 Aug;89(16):8292-303
pubmed: 26041283
J Virol. 2020 May 4;94(10):
pubmed: 32132240
J Virol. 2018 Jun 29;92(14):
pubmed: 29695432
J Virol. 1998 Mar;72(3):2310-5
pubmed: 9499091
J Biol Chem. 1996 Nov 8;271(45):28567-71
pubmed: 8910486
J Virol. 2020 Mar 17;94(7):
pubmed: 31941782
J Virol. 2015 Nov;89(22):11420-37
pubmed: 26339054
J Virol. 2021 Sep 27;95(20):e0097321
pubmed: 34319778
J Virol. 2017 May 12;91(11):
pubmed: 28356528
J Virol. 2021 Feb 24;95(6):
pubmed: 33328310
EMBO J. 1994 Jun 15;13(12):2925-34
pubmed: 7517863
J Gen Virol. 2008 Mar;89(Pt 3):676-686
pubmed: 18272758
Virology. 2007 Feb 5;358(1):221-32
pubmed: 16979682
J Virol. 2018 Jun 29;92(14):
pubmed: 29695431
J Virol. 1988 Jun;62(6):2124-33
pubmed: 2835514
J Virol. 1998 Aug;72(8):6546-53
pubmed: 9658098
J Virol. 2007 Jan;81(2):872-83
pubmed: 17093195
J Virol. 2018 Mar 28;92(8):
pubmed: 29367248
J Virol. 2015 Nov;89(21):11030-45
pubmed: 26311875
J Virol. 2015 Mar;89(6):3145-62
pubmed: 25552719
J Biol Chem. 2014 Feb 28;289(9):5635-53
pubmed: 24407286
PLoS Negl Trop Dis. 2020 May 29;14(5):e0008336
pubmed: 32469886
J Virol Methods. 2008 Mar;148(1-2):265-70
pubmed: 18054090
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9558-9567
pubmed: 31000599
Virus Res. 2018 May 2;250:31-36
pubmed: 29630910
Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):507-11
pubmed: 7831320
J Virol. 1993 Apr;67(4):1905-15
pubmed: 8445716
J Virol. 2012 Jan;86(1):553-65
pubmed: 22031949
PLoS Pathog. 2016 Aug 10;12(8):e1005810
pubmed: 27509095
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14622-7
pubmed: 22908261
EMBO J. 1999 Jun 1;18(11):3164-72
pubmed: 10357827
Nature. 2021 Jan;589(7843):615-619
pubmed: 33328629
Cell Host Microbe. 2021 May 12;29(5):757-764.e3
pubmed: 33730549
J Virol. 2003 Feb;77(3):1691-702
pubmed: 12525603
J Virol. 2013 Sep;87(18):10295-312
pubmed: 23864636
Nucleic Acids Res. 2019 Sep 26;47(17):9296-9312
pubmed: 31350895
J Virol. 2013 Sep;87(18):10207-20
pubmed: 23864614
J Virol. 2008 Jul;82(13):6218-31
pubmed: 18417571
J Virol. 2019 Aug 28;93(18):
pubmed: 31217251
Virology. 2009 Feb 5;384(1):201-8
pubmed: 19036396
J Virol. 2015 Aug;89(15):7536-49
pubmed: 25972559
J Virol. 2017 Jul 12;91(15):
pubmed: 28539441
PLoS Negl Trop Dis. 2013;7(1):e1931
pubmed: 23359824
J Virol. 2015 Jan 15;89(2):1404-18
pubmed: 25392227
Microb Biotechnol. 2014 Sep;7(5):480-4
pubmed: 24418177
J Gen Virol. 2018 Jun;99(6):761-762
pubmed: 29745869
J Gen Virol. 2020 Jan;101(1):96-104
pubmed: 31674898
J Virol. 2007 Apr;81(8):4371-3
pubmed: 17287268
J Virol. 2006 Oct;80(20):9962-9
pubmed: 17005674
PLoS Pathog. 2020 Sep 4;16(9):e1008825
pubmed: 32886709
J Virol. 2018 Jul 31;92(16):
pubmed: 29899097
Antiviral Res. 2017 Jul;143:38-47
pubmed: 28390873
J Gen Virol. 2015 Sep;96(9):2483-2500
pubmed: 26219641
J Virol. 2010 Aug;84(15):7543-57
pubmed: 20484502
Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9429-34
pubmed: 15197279
J Virol. 2006 May;80(10):4992-7
pubmed: 16641290
J Gen Virol. 2017 Jan;98(1):43-49
pubmed: 28206905
J Virol. 2017 Jun 26;91(14):
pubmed: 28468889
J Gen Virol. 2007 Jul;88(Pt 7):1977-1985
pubmed: 17554031
J Virol. 2013 Aug;87(16):9125-34
pubmed: 23760239
Virology. 2015 Jan 1;474:154-62
pubmed: 25463613
J Virol. 2007 Mar;81(5):2472-84
pubmed: 17108023
J Virol. 2009 Sep;83(17):8327-39
pubmed: 19515761
Virology. 1992 Dec;191(2):932-40
pubmed: 1448929
Microbiol Resour Announc. 2020 Jan 9;9(2):
pubmed: 31919150
J Virol. 2020 Nov 23;94(24):
pubmed: 32999019
J Biol Chem. 2000 Jun 9;275(23):17281-7
pubmed: 10748213
J Virol. 2010 Nov;84(22):11679-95
pubmed: 20826696
Sci Rep. 2016 Nov 15;6:37124
pubmed: 27845418
mBio. 2017 Nov 14;8(6):
pubmed: 29138302
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16534-9
pubmed: 23010928

Auteurs

Laura Sandra Lello (LS)

Institute of Technology, University of Tartugrid.10939.32, Tartu, Estonia.

Koen Bartholomeeusen (K)

Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Sainan Wang (S)

Institute of Technology, University of Tartugrid.10939.32, Tartu, Estonia.

Sandra Coppens (S)

Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Rennos Fragkoudis (R)

University of Nottingham, School of Veterinary Medicine and Science, Loughborough, United Kingdom.

Luke Alphey (L)

The Pirbright Institute, Woking, United Kingdom.

Kevin K Ariën (KK)

Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

Andres Merits (A)

Institute of Technology, University of Tartugrid.10939.32, Tartu, Estonia.

Age Utt (A)

Institute of Technology, University of Tartugrid.10939.32, Tartu, Estonia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH